Novavax ends COVID vaccine sale agreement with Gavi Business, Therapeutics The company cited Gavi’s failure to procure the 350 million doses it had agreed to buy in May last year for the COVAX facility. Read more November 21, 2022/by Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/11/Novavax-sees-start-of-U.S.-COVID-19-vaccine-trial-in-coming-weeks-after-second-delay-Reuters-11-30-20.jpeg 243 370 Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Reuters Health2022-11-21 18:15:142022-11-22 09:42:21Novavax ends COVID vaccine sale agreement with Gavi
